HK Stock Market Move | HESAI-W(02525) surged nearly 3% and jointly released the Siasun Robot & Automation laser radar solution with Fibocom Wireless Inc., which has been implemented by leading intelligent companies.
Wheat Sai-W (02525) rose nearly 3%, as of the time of publication, it rose 2.29%, to 183.4 Hong Kong dollars, with a turnover of 9.4988 million Hong Kong dollars.
HESAI-W(02525) rose nearly 3%, with an increase of 2.29% at the time of publication, reaching 183.4 Hong Kong dollars, with a turnover of 9.4988 million Hong Kong dollars.
In terms of news, according to a message from Hesai Technology's official WeChat account, Hesai Technology recently reached a strategic partnership with Fibocom Wireless Inc. to jointly release a multi-mode fusion perception and control solution based on laser radar for Siasun Robot&Automation. The cooperation focuses on popular areas such as human intelligence, quadruped robot dogs, and grass cutting Siasun Robot&Automation, with 3D laser radar technology and AI visual algorithms at its core. This collaboration aims to help Siasun Robot&Automation achieve key functions such as precise positioning, environmental perception and obstacle avoidance, path planning and navigation, injecting new energy into the intelligent upgrade of the Siasun Robot&Automation industry. Currently, this solution has been successfully applied to a leading human intelligence company in China, empowering its new generation benchmark Siasun Robot&Automation products.
This cooperation between Hesai Technology and Fibocom Wireless Inc. will integrate Hesai Technology's perception hardware advantages with Fibocom Wireless Inc.'s artificial intelligence technology, and is expected to continue to make breakthroughs in scenarios such as smart homes, intelligent manufacturing, and smart logistics in the future. This will drive the deep integration of laser radar and AI algorithms, accelerating the industrial deployment process of intelligent Siasun Robot&Automation.
 Related Articles 

Haisco Pharmaceutical (688302.SH): The Phase II clinical trial for the treatment of metabolic associated fatty liver disease (MASH) drug HP515 has completed the enrollment of the first batch of participants.

Harson Trading (China) Co., Ltd. (603958.SH) plans to sell 51% equity of Harson Xin Zhi to optimize asset structure.

Ranked eighth! REPT BATTERO (00666) reclaims the top spot on Bloomberg's New Energy Finance Tier 1 list of energy storage manufacturers.
Haisco Pharmaceutical (688302.SH): The Phase II clinical trial for the treatment of metabolic associated fatty liver disease (MASH) drug HP515 has completed the enrollment of the first batch of participants.

Harson Trading (China) Co., Ltd. (603958.SH) plans to sell 51% equity of Harson Xin Zhi to optimize asset structure.

Ranked eighth! REPT BATTERO (00666) reclaims the top spot on Bloomberg's New Energy Finance Tier 1 list of energy storage manufacturers.






